MAPK8 and gastric cancer: VEGFA derived from PMCs acts on VEGFR1 in GC cells under hypoxic conditions, thereby activating the p-ERK/p-JNK pathway and increasing the expression of integrin α5 and fibronectin, which are key factors that promote PM of GC.